Press release
Oncolytic Virus Therapies Market Size, Share, Development Strategy, Revenue By 2028
Oncolytic Virus Therapies Market
The global oncolytic virus therapies market size is expected to reach USD 609.7 Million at a steady CAGR of 26.2% in 2028, according to latest analysis by Emergen Research. Rise in prevalence of cancer, increase in number of clinical trials and investment in research & development for cancer therapies are driving the growth of oncolytic virus therapies market.
Oncolytic virus is a virus which infects and kills cancer cells and as these cancer cells are destroyed by oncolysis, they release new infectious particles which destroy remaining tumor. Cancer mortality rate is 158.3 per 100,000 people per year. Estimated national expense for cancer in the U.S. was USD 150.8 billion in 2018. This cost is likely to increase as population ages and need for development of new effective therapies will fuel oncolytic virus therapies market growth.
Get a sample copy of the report @ https://www.emergenresearch.com/request-sample/704
The report further explores the key companies and their product portfolios to impart a better understanding of the competitive landscape. Along with the profiles, the sections also offer insights into their market size, market share, global position, financial standing, business overview, and strategic initiatives, such as product developments, technological advancements, mergers & acquisitions, joint ventures, partnerships, and collaborations, among others, undertaken by companies.
The report covers the profiling of the following key companies:
Oncolytics Biotech, Inc., Amgen Inc., Sorrento Therapeutics, Inc., Transgene SA, Daiichi Sankyo Company, Limited, Shanghai Sunway Biotech Co., Ltd., Takara Bio Inc., PsiOxus Therapeutics, SillaJen, Inc., and ViroCure.
Some Key Highlights in the Report
• In January 2021, Enara Bio and Boehringer Ingelheim announced a strategic collaboration and licensing agreement for R&D of novel targeted cancer immunotherapy. The new collaboration combines Boehringer’s approach to treat cancer through pairing science with innovative platforms such as oncolytic virus and cancer vaccines, with Enara’s expertise in cancer antigen identification.
• Rise in number of research institutes for development of effective therapies and drugs to treat and study cancer, particularly in developing countries, is driving the growth of cancer research institute segment. Increased investment by private and government sectors into these institutions is driving segment growth.
• North America accounted for the largest revenue share in 2020. The U.S. is the primary contributor and is expected to witness high growth due to the large amount of funding by the private firms and government for clinical trials. Other factors driving the oncolytic virus therapies market are an increase in research and development initiatives to develop therapeutic options for chronic diseases, easy approval for clinical trials, and availability of highly sophisticated research infrastructure.
Furthermore, the report offers insights into the segmentation of the Oncolytic Virus Therapies industry based on product types, applications, end-user, technology, and key regions. The study also assesses the market segment expected to show significant growth in the coming years.
• Virus Type Outlook (Revenue, USD Million; 2018–2028)
o Genetically Engineered Oncolytic Viruses
1. Herpes Simplex Virus
2. Adenovirus
3. Vaccinia Virus
o Oncolytic Wild-Type Viruses
1. Reovirus
2. Newcastle Disease Virus
3. Vesicular Stomatitis Virus
• Application Outlook (Revenue, USD Million; 2018–2028)
o Solid Tumors
1. Breast Cancer
2. Prostate Cancer
3. Lung Cancer
4. Glioblastoma
o Melanoma
1. Hematological Malignancies
2. Lymphoma
3. Leukemia
4. Myeloma
• End-use Outlook (Revenue, USD Million; 2018–2028)
o Hospitals
o Specialty Clinics
o Cancer Research Institute
Regional Analysis of the Oncolytic Virus Therapies Market includes:
• North America(U.S.A., Canada)
• Europe(U.K., Italy, Germany, France, Rest of EU)
• AsiaPacific(India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America(Chile, Brazil, Argentina, Rest of Latin America)
• Middle East & Africa(Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/704
Key Features of the Oncolytic Virus Therapies Market Report:
• The report encompasses Oncolytic Virus Therapies market overview along with market share, demand and supply ratio, production and consumption patterns, supply chain analysis, and other ley elements
• An in-depth analysis of the different approaches and procedures undertaken by the key players to conduct business efficiently
• Offers insights into production and manufacturing value, products and services offered in the market, and fruitful information about investment strategies
• Supply chain analysis along with technological advancements offered in the report
• The report provides an extensive analysis of the trends, drivers, restraints, limitations, threats, and growth opportunities in the Oncolytic Virus Therapies industry
The report offers a sophisticated analysis of the market statistics and is represented in graphs, tables, facts, figures, diagrams, and charts to provide a better understanding of the Oncolytic Virus Therapies industry.
The report considers the following years for estimation of the market size:
Historical Years: 2018-2019
Base Year: 2020
Estimated Year: 2028
Forecast Years: 2021-2028
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2020-2028
Chapter 3. Key Insights
Chapter 4. Oncolytic Virus Therapies Market Segmentation & Impact Analysis
4.1. Oncolytic Virus Therapies Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Rising number of clinical trials
4.2.2.2. Increasing adoption of inorganic growth strategies in the market
4.2.3. Market restraints analysis
4.2.3.1. High cost of therapy
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Oncolytic Virus Therapies Market By Virus Type Insights & Trends, Revenue (USD Million)
5.1. Virus Type Dynamics & Market Share, 2021 & 2028
5.1.1. Genetically Engineered Oncolytic Viruses
5.1.1.1. Herpes Simplex Virus
5.1.1.2. Adenovirus
5.1.1.3. Vaccinia Virus
5.1.2. Oncolytic Wild-Type Viruses
5.1.2.1. Reovirus
5.1.2.2. Newcastle Disease Virus
5.1.2.3. Vesicular Stomatitis Virus
READ MORE…!
To read more about the report @ https://www.emergenresearch.com/industry-report/oncolytic-virus-therapies-market
Thank you for reading our report. Customization is available in the report. To know more, please connect with us and our team will ensure the report is customized as per your requirements.
Read similar reports by Emergen Research:
Multi-Rotor Drone Market@ https://www.google.fm/url?q=https://www.emergenresearch.com/industry-report/multi-rotor-drone-market
Target Drones Market@ https://www.google.md/url?q=https://www.emergenresearch.com/industry-report/target-drones-market
Drip Irrigation Market@ https://www.google.mn/url?q=https://www.emergenresearch.com/industry-report/drip-irrigation-market
Soil Stabilization Market@ https://www.google.me/url?q=https://www.emergenresearch.com/industry-report/soil-stabilization-market
Medical Wearable Market@ https://www.google.ms/url?q=https://www.emergenresearch.com/industry-report/medical-wearable-market
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oncolytic Virus Therapies Market Size, Share, Development Strategy, Revenue By 2028 here
News-ID: 2338272 • Views: …
More Releases from Emergen Research
Helicopter Swashplate Market Size Worth USD 89.69 Billion 2032 | Emergen Researc …
The global helicopter swashplate market size was USD 46.68 Billion in 2022 and is expected to register a revenue CAGR of 6.7% during the forecast period, according to the latest analysis by Emergen Research. Increasing focus on predictive maintenance is a major factor driving the market revenue growth. Integration of sensor technology and data analytics in swashplate systems enables real-time monitoring of its condition and performance. This trend facilitates predictive…
Non Airbreathing Propulsion System Market Size Worth USD 8.70 Billion 2032 | Eme …
The global non-airbreathing propulsion system market size is expected to reach USD 8.70 Billion in 2032 and register a steady revenue CAGR of 5.5% during the forecast period, according to latest analysis by Emergen Research. Increasing commercial application of non-airbreathing propulsion systems is a key factor driving market revenue growth. Non-air-breathing propulsion systems does not use air to move objects and include electric motors, hydraulic motors, and steam engines. These…
Aircraft Auxiliary Power Unit (APU) Market Size Worth USD 4.88 Billion 2032 | Em …
The global aircraft Auxiliary Power Unit (APU) market size is expected to reach USD 4.88 Billion in 2032 and register a steady revenue CAGR of 4.2% over the forecast period, according to the latest analysis by Emergen Research. Ongoing technical developments in APUs, including creation of smaller, lighter, and units with better performance and power-to-weight ratios, is a key factor driving market revenue growth. Major companies are concentrating on creating…
Red Dot Sight Market Size Will Achieve USD 96.9 Million by 2032 With Growing at …
The global red dot sight market size was USD 59.8 Million in 2022 and is expected to register a steady revenue CAGR of 5.0% during the forecast period, according to latest analysis by Emergen Research. Rising demand for advanced aiming solutions in defense and military applications is the primary factor driving market revenue growth. A red dot sight is a weapon optic that projects a brilliant dot-shaped reticle at 1x…
More Releases for Virus
Zika Virus Vaccines Market 2022 | High rate of incidence of active Zika virus in …
Zika Virus Vaccines Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $18,697 million by 2022, registering a CAGR of 5.2% during the forecast period 2017-2022.Key opportunities include the need for vaccines for immunization & prevention of further spread of Zika virus infection and for treatment of Zika-linked birth defects.
Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/1817
The outbreak of Zika virus infection in Latin…
Viral Disease Diagnosis Market - Revolutionary Trends 2025 | Cytomegalovirus, De …
Global Viral Disease Diagnosis Market: Snapshot
Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.…
Viral Disease Diagnosis Market to See Huge Growth by 2025 | Measles Virus, Polio …
Global Viral Disease Diagnosis Market: Snapshot
Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.…
Virus Free Corporate Training
Interaction for learning is critical but our customers are slowly starting to realise that this doesn’t necessarily need to take place face to face. Virtual instructor led training (VILT) makes learning more accessible by removing geographical barriers. It helps improve user product adoption, knowledge and career development and eliminates the need for costly and time-consuming travel. Still, there’s often a misconception that in person training is the only type of…
Tick-borne Encephalitis Inactivated Vaccine Market Report 2018: Segmentation by …
Global Tick-borne Encephalitis Inactivated Vaccine market research report provides company profile for Pfizer Inc., Encephalitis Global, Inc., The Cochrane Collaboration, Sonic HealthPlus Pty Ltd., Superdrug Health Clinic, GlaxoSmithKline plc, Merck & Co., Inc., Baxter International Inc., London Travel Clinic and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of…
Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Deve …
"The Latest Research Report Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review, 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
This report provides an overview of the pipeline landscape for the respiratory tract infections respiratory syncytial virus (RSV) and human parainfluenza virus 3 (HPIV-3).
It provides comprehensive information on the therapeutics under development and key players involved…
